Equities

Milestone Scientific Inc

Milestone Scientific Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.6751
  • Today's Change-0.025 / -3.57%
  • Shares traded61.65k
  • 1 Year change-20.48%
  • Beta1.0067
Data delayed at least 15 minutes, as of Nov 13 2024 18:40 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Milestone Scientific Inc. is a biomedical technology company. The Company patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The Company operates through two segments: dental and medical. The Company has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. Its device, using The Wand, a single-use disposable handpiece, is marketed in dentistry under the trademarks CompuDent and STA Single Tooth Anesthesia System, and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in over 41 other countries. In addition, the Company has obtained CE mark approval for certain medical devices, which can be marketed and sold in various European countries.

  • Revenue in USD (TTM)8.42m
  • Net income in USD-4.62m
  • Incorporated1989
  • Employees17.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
DIH Holding US Inc67.62m-6.14m46.63m192.00------0.6896-0.1903-0.19031.96-0.98411.994.1211.80352,161.50-18.09------48.86---9.09--0.4221-3.38----19.26---732.64------
Nexalin Technology Inc150.16k-5.40m48.62m6.00--21.23--323.77-0.7261-0.72610.02020.17810.04460.167911.5325,026.67-160.37---202.23--82.94---3,598.50--4.89--0.00---91.62---173.80------
Vivos Inc25.00k-2.81m48.85m10.00--30.53--1,954.20-0.0075-0.00750.000070.00380.014--2.56---157.67-202.25-171.09-552.77-3.1210.79-11,223.64-11,969.07----0.00---46.58---17.19------
Accelerate Diagnostics Inc11.91m-53.46m49.09m134.00------4.12-2.72-2.720.5826-1.950.33252.765.0888,873.13-149.23-75.24-685.54-94.4624.2535.08-448.86-638.551.34-2.556.01---5.4316.291.40--0.7307--
Harvard Apparatus Regenertv Tchnlgy Inc216.00k-7.97m49.40m10.00------228.71-0.5682-0.56820.0154-0.02030.0575----21,600.00-212.20-330.30-448.71-1,524.8877.31---3,689.35-35,138.840.2992--2.38-------44.28---39.07--
Cytosorbents Corp37.74m-18.67m53.04m186.00--4.07--1.41-0.3617-0.36170.72030.23850.79144.525.89202,900.80-39.15-36.00-49.80-43.5262.7168.15-49.47-62.711.58--0.515--4.7910.0613.12---9.24--
Rapid Micro Biosystems Inc26.17m-48.40m53.79m193.00--0.6358--2.06-1.11-1.110.60281.970.20451.326.78135,595.90-37.81---43.12---4.82---184.93--4.19------31.44--13.71------
Lucid Diagnostics Inc3.80m-54.15m53.99m70.00------14.21-1.23-1.230.08570.32380.0992--38.9754,285.71-121.82---274.96---67.39---1,227.76--1.71--0.4178--544.03--6.24------
Milestone Scientific Inc8.42m-4.62m54.11m17.00--6.79--6.42-0.0614-0.06140.10960.1030.72740.576314.32495,440.60-40.16-55.48-56.48-74.7272.4463.97-55.21-88.941.81--0.0007--11.600.423320.41---7.99--
Apyx Medical Corp48.54m-28.44m55.59m252.00--4.30--1.15-0.821-0.8211.400.31870.80791.893.78192,627.00-47.47-25.24-57.09-29.9760.4166.11-58.76-46.004.52-5.970.7518--17.6125.8219.28--7.99--
Nutriband Inc1.80m-7.24m56.04m13.00--4.50--31.07-0.8122-0.81220.19841.120.15356.2912.38---61.64-55.21-67.30-66.7433.6233.32-401.62-315.876.36--0.0156--0.274153.43-22.35--65.57--
Singular Genomics Systems Inc2.72m-91.89m57.33m255.00--0.4156--21.06-37.37-37.371.1155.270.01080.286711.5310,674.51-36.46---38.85---41.11---3,375.72--8.04--0.0696--280.52---4.34------
Alpha Pro Tech, Ltd.59.29m4.14m57.74m124.0014.330.926511.290.9740.36640.36645.245.670.85961.689.07478,121.006.0115.216.2216.0639.5540.236.9912.9311.21--0.000.00-1.215.6027.642.935.50--
IR-Med Inc0.00-3.47m58.01m6.00--159.71-----0.0499-0.04990.000.00510.00----0.00-197.95---273.36--------------0.3019-------3.70------
Medinotec Inc8.38m-21.86k58.67m35.00----755.657.00-0.0019-0.00190.71460.21561.645.0217.62239,561.70-0.4275---0.5122--42.89---0.2607--2.326.610.3165--402.25---14.73------
InspireMD Inc6.57m-25.52m61.31m65.00--1.29--9.34-0.7389-0.73890.19071.860.12022.574.73101,030.80-46.71-60.59-52.36-72.9723.8520.46-388.67-334.787.13--0.00--20.0011.50-7.71--41.57--
Data as of Nov 13 2024. Currency figures normalised to Milestone Scientific Inc's reporting currency: US Dollar USD

Institutional shareholders

4.76%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 20242.13m2.76%
Geode Capital Management LLCas of 30 Jun 2024495.43k0.64%
Bridgeway Capital Management LLCas of 30 Jun 2024401.70k0.52%
Carnegie Capital Asset Management LLCas of 30 Sep 2024145.20k0.19%
Mariner LLCas of 30 Jun 2024121.75k0.16%
SSgA Funds Management, Inc.as of 30 Jun 2024117.79k0.15%
Northern Trust Investments, Inc.(Investment Management)as of 30 Jun 202494.69k0.12%
BlackRock Fund Advisorsas of 30 Jun 202470.53k0.09%
Citadel Securities LLCas of 30 Jun 202454.33k0.07%
Sequoia Financial Advisors LLCas of 30 Sep 202445.00k0.06%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.